The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer
Open accessAbstract
BACKGROUND: We compared concomitant cisplatin and irradiation with radiotherapy alone as adjuvant treatment for stage III or IV head and neck cancer. METHODS: After undergoing surgery with curative intent, 167 patients were randomly assigned to receive radiotherapy alone (66 Gy over a period of 6 1/2 weeks) and 167 to receive the same radiotherapy regimen combined with 100 mg of cisplatin per square meter of body-surface area on days 1, 22, and 43 of the radiotherapy regimen. RESULTS: After a median follow-up of 60 months, the rate of progression-free survival was significantly higher in the combined-therapy group than in the group given radiotherapy alone (P=0.04 by the log-rank test; hazard ratio for disease progression, 0.75; 95 percent confidence interval, 0.56 to 0.99), with 5-year Kaplan-Meier estimates of progression-free survival of 47 percent and 36 percent, respectively. The overall survival rate was also significantly higher in the combined-therapy group than in the radiotherapy group (P=0.02 by the log-rank test; hazard ratio for death, 0.70; 95 percent confidence interval, 0.52 to 0.95), with five-year Kaplan-Meier estimates of overall survival of 53 percent and 40 percent, respectively. The cumulative incidence of local or regional relapses was significantly lower in the combined-therapy group (P=0.007). The estimated five-year cumulative incidence of local or regional relapses (considering death from other causes as a competing risk) was 31 percent after radiotherapy and 18 percent after combined therapy. Severe (grade 3 or higher) adverse effects were more frequent after combined therapy (41 percent) than after radiotherapy (21 percent, P=0.001); the types of severe mucosal adverse effects were similar in the two groups, as was the incidence of late adverse effects. CONCLUSIONS: Postoperative concurrent administration of high-dose cisplatin with radiotherapy is more efficacious than radiotherapy alone in patients with locally advanced head and neck cancer and does not cause an undue number of late complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
Gray, R. J. (1988) · The Annals of Statistics · doi:10.1214/aos/1176350951 · Cited by 4,960
Cooper, J. S., Pajak, T. F., Forastiere, A. A., Jacobs, J., Campbell, B. H., Saxman, S. B., Kish, J. A., Kim, H. E., Cmelak, A. J., Rotman, M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032646 · Cited by 3,269
Pignon, J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)90011-0 · Cited by 2,543
Brizel, D. M., Albers, M. E., Fisher, S. R., Scher, R. L., Richtsmeier, W. J., Hars, V., George, S. L., Huang, A. T., & Prosnitz, L. R. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806183382503 · Cited by 1,127
Calais, G., Alfonsi, M., Bardet, E., Sire, C., Germain, T., Bergerot, P., Rhein, B., Tortochaux, J., Oudinot, P., & Bertrand, P. (1999) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/91.24.2081 · Cited by 1,060
Robbins, K. T., Medina, J. E., Wolfe, G. T., Levine, P. A., Sessions, R. B., & Pruet, C. W. (1991) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.1991.01870180037007 · Cited by 809
Wendt, T. G., Grabenbauer, G. G., Rödel, C. M., Thiel, H. J., Aydin, H., Rohloff, R., Wustrow, T. P., Iro, H., Popella, C., & Schalhorn, A. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.4.1318 · Cited by 634
Peters, L. J., Goepfert, H., Ang, K. K., Byers, R. M., Maor, M. H., Guillamondegui, O., Morrison, W. H., Weber, R. S., Garden, A. S., Frankenthaler, R. A., et al. (1993) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(93)90167-t · Cited by 538
Cited by
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
Ferris, R. L., Blumenschein, G., Fayette, J., Guigay, J., Colevas, A. D., Licitra, L., Harrington, K., Kasper, S., Vokes, E. E., Even, C., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1602252 · Cited by 5,101
Head and neck squamous cell carcinoma
Johnson, D. E., Burtness, B., Leemans, C. R., Lui, V. W. Y., Bauman, J. E., & Grandis, J. R. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00224-3 · Cited by 4,067
Cooper, J. S., Pajak, T. F., Forastiere, A. A., Jacobs, J., Campbell, B. H., Saxman, S. B., Kish, J. A., Kim, H. E., Cmelak, A. J., Rotman, M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032646 · Cited by 3,269
Argiris, A., Karamouzis, M. V., Raben, D., & Ferris, R. L. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60728-x · Cited by 2,224
Chow, L. Q. M. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1715715 · Cited by 2,075
Bernier, J., Cooper, J. S., Pajak, T. F., van Glabbeke, M., Bourhis, J., Forastiere, A., Ozsahin, E. M., Jacobs, J. R., Jassem, J., Ang, K.-K., et al. (2005) · Head & Neck · doi:10.1002/hed.20279 · Cited by 1,772
Self-citationCisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
Posner, M. R., Hershock, D. M., Blajman, C. R., Mickiewicz, E., Winquist, E., Gorbounova, V., Tjulandin, S., Shin, D. M., Cullen, K., Ervin, T. J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070956 · Cited by 1,705
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Oral cavity and oropharyngeal squamous cell carcinoma—an update
Chi, A. C., Day, T. A., & Neville, B. W. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21293 · Cited by 1,094
Recent Advances in Head and Neck Cancer
Haddad, R. I., & Shin, D. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0707975 · Cited by 916
Machiels, J.-P., René Leemans, C., Golusinski, W., Grau, C., Licitra, L., & Gregoire, V. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.07.011 · Cited by 916
Mody, M. D., Rocco, J. W., Yom, S. S., Haddad, R. I., & Saba, N. F. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01550-6 · Cited by 847
Haddad, R., O'Neill, A., Rabinowits, G., Tishler, R., Khuri, F., Adkins, D., Clark, J., Sarlis, N., Lorch, J., Beitler, J. J., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70011-1 · Cited by 750
Head and Neck Cancer: Changing Epidemiology, Diagnosis, and Treatment
Marur, S., & Forastiere, A. A. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.4.489 · Cited by 739
Cohen, E. E. W., Bell, R. B., Bifulco, C. B., Burtness, B., Gillison, M. L., Harrington, K. J., Le, Q.-T., Lee, N. Y., Leidner, R., Lewis, R. L., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0662-5 · Cited by 722
Wee, J., Tan, E. H., Tai, B. C., Wong, H. B., Leong, S. S., Tan, T., Chua, E. T., Yang, E., Lee, K. M., Fong, K. W., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.16.790 · Cited by 650
Montero, P. H., & Patel, S. G. (2015) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2015.03.006 · Cited by 629
Grégoire, V., Lefebvre, J.-L., Licitra, L., & Felip, E. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq185 · Cited by 628
Cooper, J. S., Zhang, Q., Pajak, T. F., Forastiere, A. A., Jacobs, J., Saxman, S. B., Kish, J. A., Kim, H. E., Cmelak, A. J., Rotman, M., et al. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.05.008 · Cited by 598
Saâda-Bouzid, E., Defaucheux, C., Karabajakian, A., Coloma, V. P., Servois, V., Paoletti, X., Even, C., Fayette, J., Guigay, J., Loirat, D., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx178 · Cited by 596
Caudell, J. J., Gillison, M. L., Maghami, E., Spencer, S., Pfister, D. G., Adkins, D., Birkeland, A. C., Brizel, D. M., Busse, P. M., Cmelak, A. J., et al. (2022) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2022.0016 · Cited by 526
Oral complications of cancer and cancer therapy: From cancer treatment to survivorship
Epstein, J. B., Thariat, J., Bensadoun, R., Barasch, A., Murphy, B. A., Kolnick, L., Popplewell, L., & Maghami, E. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21157 · Cited by 518
Molecular Pathogenesis of Oral Squamous Cell Carcinoma: Implications for Therapy
Choi, S., & Myers, J. N. (2008) · Journal of Dental Research · doi:10.1177/154405910808700104 · Cited by 516
Pfister, D. G., Laurie, S. A., Weinstein, G. S., Mendenhall, W. M., Adelstein, D. J., Ang, K. K., Clayman, G. L., Fisher, S. G., Forastiere, A. A., Harrison, L. B., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.4559 · Cited by 496
Predictors of Competing Mortality in Advanced Head and Neck Cancer
Mell, L. K., Dignam, J. J., Salama, J. K., Cohen, E. E. W., Polite, B. N., Dandekar, V., Bhate, A. D., Witt, M. E., Haraf, D. J., Mittal, B. B., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.9288 · Cited by 433
Pfister, D. G., Ang, K.-K., Brizel, D. M., Burtness, B. A., Cmelak, A. J., Colevas, A. D., Dunphy, F., Eisele, D. W., Gilbert, J., Gillison, M. L., et al. (2011) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2011.0053 · Cited by 413
Oral Cavity Carcinoma: Current Management, Controversies, and Future Directions
Chinn, S. B., & Myers, J. N. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.2929 · Cited by 412
Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancers
Winter, S. C., Buffa, F. M., Silva, P., Miller, C., Valentine, H. R., Turley, H., Shah, K. A., Cox, G. J., Corbridge, R. J., Homer, J. J., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3322 · Cited by 410
“Surgery, radiotherapy, and chemotherapy play a role in the management of the disease, and 5-year survival rates for patients with advanced cancers are f50% (2, 3).”
BackgroundNeoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer
Uppaluri, R., Haddad, R. I., Tao, Y., Le Tourneau, C., Lee, N. Y., Westra, W., Chernock, R., Tahara, M., Harrington, K. J., Klochikhin, A. L., et al. (2025) · New England Journal of Medicine · doi:10.1056/nejmoa2415434 · Cited by 410
Koyfman, S. A., Ismaila, N., Crook, D., D'Cruz, A., Rodriguez, C. P., Sher, D. J., Silbermins, D., Sturgis, E. M., Tsue, T. T., Weiss, J., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.01921 · Cited by 395
Zhong, L.-P., Zhang, C.-P., Ren, G.-X., Guo, W., William, W. N., Sun, J., Zhu, H.-G., Tu, W.-Y., Li, J., Cai, Y.-L., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.8820 · Cited by 394
Lacas, B., Carmel, A., Landais, C., Wong, S. J., Licitra, L., Tobias, J. S., Burtness, B., Ghi, M. G., Cohen, E. E. W., Grau, C., et al. (2021) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2021.01.013 · Cited by 389
Self-citation18F-FDG PET/CT Imaging In Oncology
Almuhaideb, A., Papathanasiou, N., & Bomanji, J. (2011) · Annals of Saudi Medicine · doi:10.4103/0256-4947.75771 · Cited by 388
Uppaluri, R., Campbell, K. M., Egloff, A. M., Zolkind, P., Skidmore, Z. L., Nussenbaum, B., Paniello, R. C., Rich, J. T., Jackson, R., Pipkorn, P., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-1695 · Cited by 384
NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017
Adelstein, D., Gillison, M. L., Pfister, D. G., Spencer, S., Adkins, D., Brizel, D. M., Burtness, B., Busse, P. M., Caudell, J. J., Cmelak, A. J., et al. (2017) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2017.0101 · Cited by 371
Schoenfeld, J. D., Hanna, G. J., Jo, V. Y., Rawal, B., Chen, Y.-H., Catalano, P. S., Lako, A., Ciantra, Z., Weirather, J. L., Criscitiello, S., et al. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.2955 · Cited by 361
Worden, F. P., Kumar, B., Lee, J. S., Wolf, G. T., Cordell, K. G., Taylor, J. M. G., Urba, S. G., Eisbruch, A., Teknos, T. N., Chepeha, D. B., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.7597 · Cited by 357
Advances in Radiation Therapy: Conventional to 3D, to IMRT, to 4D, and Beyond
Bucci, M. K., Bevan, A., & Roach, M. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.117 · Cited by 354
Oral cancer: Current role of radiotherapy and chemotherapy
Huang, S., & O Sullivan, B. (2013) · Medicina Oral Patología Oral y Cirugia Bucal · doi:10.4317/medoral.18772 · Cited by 349
Noronha, V., Joshi, A., Patil, V. M., Agarwal, J., Ghosh-Laskar, S., Budrukkar, A., Murthy, V., Gupta, T., D’Cruz, A. K., Banavali, S., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.74.9457 · Cited by 343
Vos, J. L., Elbers, J. B. W., Krijgsman, O., Traets, J. J. H., Qiao, X., van der Leun, A. M., Lubeck, Y., Seignette, I. M., Smit, L. A., Willems, S. M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26472-9 · Cited by 329
Cisplatin versus carboplatin: comparative review of therapeutic management in solid malignancies
Ho, G. Y., Woodward, N., & Coward, J. I. G. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2016.03.014 · Cited by 325
Jerjes, W., Upile, T., Petrie, A., Riskalla, A., Hamdoon, Z., Vourvachis, M., Karavidas, K., Jay, A., Sandison, A., Thomas, G. J., et al. (2010) · Head & Neck Oncology · doi:10.1186/1758-3284-2-9 · Cited by 322
Graboyes, E. M., Kompelli, A. R., Neskey, D. M., Brennan, E., Nguyen, S., Sterba, K. R., Warren, G. W., Hughes-Halbert, C., Nussenbaum, B., & Day, T. A. (2019) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2018.2716 · Cited by 312
Kademani, D. (2007) · Mayo Clinic Proceedings · doi:10.4065/82.7.878 · Cited by 310
Head and Neck Cancers, Version 2.2014
Pfister, D. G., Spencer, S., Brizel, D. M., Burtness, B., Busse, P. M., Caudell, J. J., Cmelak, A. J., Colevas, A. D., Dunphy, F., Eisele, D. W., et al. (2014) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2014.0142 · Cited by 283
Owadally, W., Hurt, C., Timmins, H., Parsons, E., Townsend, S., Patterson, J., Hutcheson, K., Powell, N., Beasley, M., Palaniappan, N., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1598-x · Cited by 277
Risk factors for osteoradionecrosis after head and neck radiation: a systematic review
Nabil, S., & Samman, N. (2012) · Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology · doi:10.1016/j.tripleo.2011.07.042 · Cited by 277
Ang, K. K., & Sturgis, E. M. (2012) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2011.12.004 · Cited by 260
Omura, K. (2014) · International Journal of Clinical Oncology · doi:10.1007/s10147-014-0689-z · Cited by 257
Head and neck cancer: past, present and future
Chin, D., Boyle, G. M., Porceddu, S., Theile, D. R., Parsons, P. G., & Coman, W. B. (2006) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.6.7.1111 · Cited by 255
Perineural Invasion and Perineural Tumor Spread in Head and Neck Cancer
Bakst, R. L., Glastonbury, C. M., Parvathaneni, U., Katabi, N., Hu, K. S., & Yom, S. S. (2019) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2018.12.009 · Cited by 254
Rischin, D., Peters, L., Fisher, R., Macann, A., Denham, J., Poulsen, M., Jackson, M., Kenny, L., Penniment, M., Corry, J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.072 · Cited by 253
Head and neck cancer: An evolving treatment paradigm
Cognetti, D. M., Weber, R. S., & Lai, S. Y. (2008) · Cancer · doi:10.1002/cncr.23654 · Cited by 253
Karamboulas, C., Bruce, J. P., Hope, A. J., Meens, J., Huang, S. H., Erdmann, N., Hyatt, E., Pereira, K., Goldstein, D. P., Weinreb, I., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.10.004 · Cited by 94
Friedman, J., Moore, E. C., Zolkind, P., Robbins, Y., Clavijo, P. E., Sun, L., Greene, S., Morisada, M. V., Mydlarz, W. K., Schmitt, N., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-2209 · Cited by 88
Lechien, J. R., Briganti, G., & Vaira, L. A. (2024) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-023-08441-8 · Cited by 54
Metadata
- Authors
- Bernier, J., Domenge, C., Ozsahin, M., Matuszewska, K., Lefèbvre, J.-L., Greiner, R. H., Giralt, J., Maingon, P., Rolland, F., Bolla, M., Cognetti, F., Bourhis, J., Kirkpatrick, A., & van Glabbeke, M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-05-06
- Volume
- 350
- Issue
- 19
- Pages
- 1945-1952
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2120068217
- Cited by
- 3,192
- References
- 16
- FWCI
- 106.26
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.